Werewolf Therapeutics Inc... (HOWL)
undefined
undefined%
At close: undefined
1.70
2.72%
After-hours Dec 13, 2024, 07:23 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -37.37M -53.81M -49.98M -15.04M -10.25M
Depreciation & Amortization 1.76M 1.10M 216.00K 150.00K 25.00K
Stock-Based Compensation 8.01M 7.40M 4.09M 632.00K 559.00K
Other Working Capital -7.14M 3.42M 1.27M 1.92M -827.00K
Other Non-Cash Items 878.00K 2.17M 519.00K 627.00K 950.00K
Deferred Income Tax - - - -7.30M -117.00K
Change in Working Capital -5.89M 2.54M 2.28M 2.31M -711.00K
Operating Cash Flow -32.61M -40.60M -42.88M -18.62M -9.54M
Capital Expenditures -769.00K -3.61M -498.00K -560.00K -266.00K
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - - - -
Investing Cash Flow -769.00K -3.61M -498.00K -560.00K -266.00K
Debt Repayment 40.00M - - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 100.00K 166.00K -2.17M 94.02M 21.91M
Financial Cash Flow 58.43M 15.91M 109.43M 93.86M 21.91M
Net Cash Flow 25.05M -28.30M 66.05M 74.67M 12.10M
Free Cash Flow -33.38M -44.21M -43.37M -19.18M -9.81M